Linear IgA Bullous Dermatosis in Korea Using the Nationwide Health Insurance Database
(1) Background: Linear immunoglobulin A bullous dermatosis (LABD) is a rare autoimmune, subepidermal blistering disease, characterized by linear IgA deposits along the epidermal basement membrane. LABD is idiopathic and is associated with medication and systemic autoimmune diseases. (2) Methods: We...
Gespeichert in:
Veröffentlicht in: | Journal of clinical medicine 2024-02, Vol.13 (4), p.1159 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 4 |
container_start_page | 1159 |
container_title | Journal of clinical medicine |
container_volume | 13 |
creator | Kim, Yu Rim Kim, Ji Hyeon Kim, Sang Won Lee, Jae Min Bae, Jacob S |
description | (1) Background: Linear immunoglobulin A bullous dermatosis (LABD) is a rare autoimmune, subepidermal blistering disease, characterized by linear IgA deposits along the epidermal basement membrane. LABD is idiopathic and is associated with medication and systemic autoimmune diseases. (2) Methods: We investigated the demographic characteristics, disease course, causative agents, and associated diseases in Korean patients with LABD. The Korean Health Insurance Review and Assessment Service database was used to obtain data. We identified 670 LABD cases between 2010 and 2022. (3) Results: The annual incidence of LABD was 1.3 per 100,000 persons, with a higher prevalence in individuals ≥60 years old. The patients were treated with dapsone for 30.7 ± 56.7 days, had 1.3 ± 0.7 hospital visits, and were hospitalized for 19.8 ± 19.7 days. Risk factors, including malignancy, commonly preceded LABD. Antibiotic use, specifically vancomycin and third-generation cephalosporins, was a risk factor. The mean age of LABD diagnosis was 55.9 ± 21.7 years. (4) Conclusion: This is the first published study to assess a nationwide cohort for LABD. The incidence of LABD was higher than that in other studies. Most case reports have linked LABD with the administration of specific antibiotics; however, this study shows there were more associations with other conditions. |
doi_str_mv | 10.3390/jcm13041159 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2932436053</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A784041099</galeid><sourcerecordid>A784041099</sourcerecordid><originalsourceid>FETCH-LOGICAL-c379t-f71821349adf6690befd462d311bc3283ac95f3dc36d31fa06075818e24d6fe53</originalsourceid><addsrcrecordid>eNptkc1vEzEQxS1ERavSE3dkiQsSSrE9u_44hhZoRNReyHnleMepo1272Luq-O9x1BYKwj549PSbpxk_Qt5wdg5g2Me9GzmwhvPWvCAngim1YKDh5bP6mJyVsmf1aN0Irl6R46oa3Sh2QjbrENFmutot6ad5GNJc6CXm0U6phEJDpN9SRks3JcQdnW6RXtsppHgfeqRXaIfplq5imbONDumlnezWFnxNjrwdCp49vqdk8-Xz94urxfrm6-piuV44UGZaeMW14NAY23spDdui7xspeuB860BosM60HnoHsmreMslUq7lG0fTSYwun5P2D711OP2YsUzeG4nAYbMS6SScMiAYka6Gi7_5B92nOsU53oJiRQiv5h9rZAbsQfZqydQfTbql0Uz-aGVOp8_9Q9fY4Bpci-lD1vxo-PDS4nErJ6Lu7HEabf3acdYccu2c5Vvrt46jzdsT-N_uUGvwCPZWUfA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2930962876</pqid></control><display><type>article</type><title>Linear IgA Bullous Dermatosis in Korea Using the Nationwide Health Insurance Database</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Kim, Yu Rim ; Kim, Ji Hyeon ; Kim, Sang Won ; Lee, Jae Min ; Bae, Jacob S</creator><creatorcontrib>Kim, Yu Rim ; Kim, Ji Hyeon ; Kim, Sang Won ; Lee, Jae Min ; Bae, Jacob S</creatorcontrib><description>(1) Background: Linear immunoglobulin A bullous dermatosis (LABD) is a rare autoimmune, subepidermal blistering disease, characterized by linear IgA deposits along the epidermal basement membrane. LABD is idiopathic and is associated with medication and systemic autoimmune diseases. (2) Methods: We investigated the demographic characteristics, disease course, causative agents, and associated diseases in Korean patients with LABD. The Korean Health Insurance Review and Assessment Service database was used to obtain data. We identified 670 LABD cases between 2010 and 2022. (3) Results: The annual incidence of LABD was 1.3 per 100,000 persons, with a higher prevalence in individuals ≥60 years old. The patients were treated with dapsone for 30.7 ± 56.7 days, had 1.3 ± 0.7 hospital visits, and were hospitalized for 19.8 ± 19.7 days. Risk factors, including malignancy, commonly preceded LABD. Antibiotic use, specifically vancomycin and third-generation cephalosporins, was a risk factor. The mean age of LABD diagnosis was 55.9 ± 21.7 years. (4) Conclusion: This is the first published study to assess a nationwide cohort for LABD. The incidence of LABD was higher than that in other studies. Most case reports have linked LABD with the administration of specific antibiotics; however, this study shows there were more associations with other conditions.</description><identifier>ISSN: 2077-0383</identifier><identifier>EISSN: 2077-0383</identifier><identifier>DOI: 10.3390/jcm13041159</identifier><identifier>PMID: 38398470</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Age groups ; Antibiotics ; Autoimmune diseases ; Care and treatment ; Diagnosis ; Dosage and administration ; Genetic aspects ; Health insurance ; Immunoglobulin A ; Leprosy ; Patients ; Prescription drugs ; Purpura ; Skin diseases ; Systemic diseases</subject><ispartof>Journal of clinical medicine, 2024-02, Vol.13 (4), p.1159</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c379t-f71821349adf6690befd462d311bc3283ac95f3dc36d31fa06075818e24d6fe53</cites><orcidid>0000-0003-0860-4303 ; 0000-0001-6822-1051 ; 0000-0003-2648-0340</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38398470$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Yu Rim</creatorcontrib><creatorcontrib>Kim, Ji Hyeon</creatorcontrib><creatorcontrib>Kim, Sang Won</creatorcontrib><creatorcontrib>Lee, Jae Min</creatorcontrib><creatorcontrib>Bae, Jacob S</creatorcontrib><title>Linear IgA Bullous Dermatosis in Korea Using the Nationwide Health Insurance Database</title><title>Journal of clinical medicine</title><addtitle>J Clin Med</addtitle><description>(1) Background: Linear immunoglobulin A bullous dermatosis (LABD) is a rare autoimmune, subepidermal blistering disease, characterized by linear IgA deposits along the epidermal basement membrane. LABD is idiopathic and is associated with medication and systemic autoimmune diseases. (2) Methods: We investigated the demographic characteristics, disease course, causative agents, and associated diseases in Korean patients with LABD. The Korean Health Insurance Review and Assessment Service database was used to obtain data. We identified 670 LABD cases between 2010 and 2022. (3) Results: The annual incidence of LABD was 1.3 per 100,000 persons, with a higher prevalence in individuals ≥60 years old. The patients were treated with dapsone for 30.7 ± 56.7 days, had 1.3 ± 0.7 hospital visits, and were hospitalized for 19.8 ± 19.7 days. Risk factors, including malignancy, commonly preceded LABD. Antibiotic use, specifically vancomycin and third-generation cephalosporins, was a risk factor. The mean age of LABD diagnosis was 55.9 ± 21.7 years. (4) Conclusion: This is the first published study to assess a nationwide cohort for LABD. The incidence of LABD was higher than that in other studies. Most case reports have linked LABD with the administration of specific antibiotics; however, this study shows there were more associations with other conditions.</description><subject>Age groups</subject><subject>Antibiotics</subject><subject>Autoimmune diseases</subject><subject>Care and treatment</subject><subject>Diagnosis</subject><subject>Dosage and administration</subject><subject>Genetic aspects</subject><subject>Health insurance</subject><subject>Immunoglobulin A</subject><subject>Leprosy</subject><subject>Patients</subject><subject>Prescription drugs</subject><subject>Purpura</subject><subject>Skin diseases</subject><subject>Systemic diseases</subject><issn>2077-0383</issn><issn>2077-0383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNptkc1vEzEQxS1ERavSE3dkiQsSSrE9u_44hhZoRNReyHnleMepo1272Luq-O9x1BYKwj549PSbpxk_Qt5wdg5g2Me9GzmwhvPWvCAngim1YKDh5bP6mJyVsmf1aN0Irl6R46oa3Sh2QjbrENFmutot6ad5GNJc6CXm0U6phEJDpN9SRks3JcQdnW6RXtsppHgfeqRXaIfplq5imbONDumlnezWFnxNjrwdCp49vqdk8-Xz94urxfrm6-piuV44UGZaeMW14NAY23spDdui7xspeuB860BosM60HnoHsmreMslUq7lG0fTSYwun5P2D711OP2YsUzeG4nAYbMS6SScMiAYka6Gi7_5B92nOsU53oJiRQiv5h9rZAbsQfZqydQfTbql0Uz-aGVOp8_9Q9fY4Bpci-lD1vxo-PDS4nErJ6Lu7HEabf3acdYccu2c5Vvrt46jzdsT-N_uUGvwCPZWUfA</recordid><startdate>20240201</startdate><enddate>20240201</enddate><creator>Kim, Yu Rim</creator><creator>Kim, Ji Hyeon</creator><creator>Kim, Sang Won</creator><creator>Lee, Jae Min</creator><creator>Bae, Jacob S</creator><general>MDPI AG</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0860-4303</orcidid><orcidid>https://orcid.org/0000-0001-6822-1051</orcidid><orcidid>https://orcid.org/0000-0003-2648-0340</orcidid></search><sort><creationdate>20240201</creationdate><title>Linear IgA Bullous Dermatosis in Korea Using the Nationwide Health Insurance Database</title><author>Kim, Yu Rim ; Kim, Ji Hyeon ; Kim, Sang Won ; Lee, Jae Min ; Bae, Jacob S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c379t-f71821349adf6690befd462d311bc3283ac95f3dc36d31fa06075818e24d6fe53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Age groups</topic><topic>Antibiotics</topic><topic>Autoimmune diseases</topic><topic>Care and treatment</topic><topic>Diagnosis</topic><topic>Dosage and administration</topic><topic>Genetic aspects</topic><topic>Health insurance</topic><topic>Immunoglobulin A</topic><topic>Leprosy</topic><topic>Patients</topic><topic>Prescription drugs</topic><topic>Purpura</topic><topic>Skin diseases</topic><topic>Systemic diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Yu Rim</creatorcontrib><creatorcontrib>Kim, Ji Hyeon</creatorcontrib><creatorcontrib>Kim, Sang Won</creatorcontrib><creatorcontrib>Lee, Jae Min</creatorcontrib><creatorcontrib>Bae, Jacob S</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Yu Rim</au><au>Kim, Ji Hyeon</au><au>Kim, Sang Won</au><au>Lee, Jae Min</au><au>Bae, Jacob S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Linear IgA Bullous Dermatosis in Korea Using the Nationwide Health Insurance Database</atitle><jtitle>Journal of clinical medicine</jtitle><addtitle>J Clin Med</addtitle><date>2024-02-01</date><risdate>2024</risdate><volume>13</volume><issue>4</issue><spage>1159</spage><pages>1159-</pages><issn>2077-0383</issn><eissn>2077-0383</eissn><abstract>(1) Background: Linear immunoglobulin A bullous dermatosis (LABD) is a rare autoimmune, subepidermal blistering disease, characterized by linear IgA deposits along the epidermal basement membrane. LABD is idiopathic and is associated with medication and systemic autoimmune diseases. (2) Methods: We investigated the demographic characteristics, disease course, causative agents, and associated diseases in Korean patients with LABD. The Korean Health Insurance Review and Assessment Service database was used to obtain data. We identified 670 LABD cases between 2010 and 2022. (3) Results: The annual incidence of LABD was 1.3 per 100,000 persons, with a higher prevalence in individuals ≥60 years old. The patients were treated with dapsone for 30.7 ± 56.7 days, had 1.3 ± 0.7 hospital visits, and were hospitalized for 19.8 ± 19.7 days. Risk factors, including malignancy, commonly preceded LABD. Antibiotic use, specifically vancomycin and third-generation cephalosporins, was a risk factor. The mean age of LABD diagnosis was 55.9 ± 21.7 years. (4) Conclusion: This is the first published study to assess a nationwide cohort for LABD. The incidence of LABD was higher than that in other studies. Most case reports have linked LABD with the administration of specific antibiotics; however, this study shows there were more associations with other conditions.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>38398470</pmid><doi>10.3390/jcm13041159</doi><orcidid>https://orcid.org/0000-0003-0860-4303</orcidid><orcidid>https://orcid.org/0000-0001-6822-1051</orcidid><orcidid>https://orcid.org/0000-0003-2648-0340</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2077-0383 |
ispartof | Journal of clinical medicine, 2024-02, Vol.13 (4), p.1159 |
issn | 2077-0383 2077-0383 |
language | eng |
recordid | cdi_proquest_miscellaneous_2932436053 |
source | MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central; PubMed Central Open Access |
subjects | Age groups Antibiotics Autoimmune diseases Care and treatment Diagnosis Dosage and administration Genetic aspects Health insurance Immunoglobulin A Leprosy Patients Prescription drugs Purpura Skin diseases Systemic diseases |
title | Linear IgA Bullous Dermatosis in Korea Using the Nationwide Health Insurance Database |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T14%3A35%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Linear%20IgA%20Bullous%20Dermatosis%20in%20Korea%20Using%20the%20Nationwide%20Health%20Insurance%20Database&rft.jtitle=Journal%20of%20clinical%20medicine&rft.au=Kim,%20Yu%20Rim&rft.date=2024-02-01&rft.volume=13&rft.issue=4&rft.spage=1159&rft.pages=1159-&rft.issn=2077-0383&rft.eissn=2077-0383&rft_id=info:doi/10.3390/jcm13041159&rft_dat=%3Cgale_proqu%3EA784041099%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2930962876&rft_id=info:pmid/38398470&rft_galeid=A784041099&rfr_iscdi=true |